Loading...
DOCUMENTS
18
NOTICES
30
MOTS CLES
Genes
Anti-TNF
Anti-TNF agents
IL23
Thérapie ciblée
HIV
Neoadjuvant chemotherapy
Gene methylation
Éradication
Crohn's disease
Helicobacter pylori
Colectomy
Consensus
Inhibitor
Upper gastrointestinal tract
Inflammatory Bowel Diseases
DNA methylation
Original Article Clinical
RISK
Tailored therapy
Biomarker
Endoscopic treatment
Algorithm
Monitoring
Epigénétiques
Inflammatory bowel disease
Gene expression
Survival
Eradication
Inflammatory bowel diseases
Patients experience
Eligibility
Biologics
MICROBIOTA
Venous thromboembolism
Clinical guidelines
Disease progression
MALT
Fecal microbiota
Méthylation
Drug
Intestinal crypts
Inclusion
MORTALITY
Kidney diseases
CARCINOGENESIS
Patient-reported outcome
Clinical trial
Dysbiosis
Bactéries
Colonic epithelial primary cells
18 FDG-PET/CT
Surgery
Bacteria
Tuberculosis
Microbiote
Ulcerative colitis
Gènes
Dysbiose
Methylation
Small molecules
Rituximab plus chlorambucil
Cell adhesion
Colon
Disability
MARKER
Colon cancer
Therapeutics
T1118 translocation
Crohn’s disease
IL12
Ustekinumab
Immunosuppressant
DNA METHYLATION
Safety
Screening
Heart disease risk factors
Contraindication
Colorectal cancer
Disease Progression
Microbiota
Resistance
Over 80s
Acceptability
Primary sclerosing cholangitis
Maintenance therapy
Rituximab
Résistance
Effectiveness
Cost effectiveness
Parvimonas micra
Epigenetics
Alkylating agents
IBD
Vedolizumab
PCR
Cancer
Stricture
COLON-CANCER
Early detection of Colon Cancer using Molecular Markers and Microbiota , EA 7375 | |
---|---|
Institutions |
UPEC |
Adresse |
Université Paris-Est Créteil Groupe Hospitalier Henri Mondor Service de Gastroentérologie 51 Av Maréchal de Lattre de Tassigny 94010 Créteil cedex |
Courriel |
|
Site Internet |
|
Rattachement(s) |
|
Direction |
Aurélien AMIOT |
Adjoint |
Iradj SOBHANI |
Axe(s) de recherche
|
Le laboratoire axe ses recherches sur le rôle du microbiome intestinal ainsi que des changements épigénétiques dans l'intestin afin :
|